Wang Y, Fan X H, Qu H B, et al. Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine[J]. Curr Top Med Chem, 2012, 12(12): 1356.
Wang L L, Li Z, Zhao X P, et al. A network study of Chinese medicine Xuesaitong injection to elucidate a complex mode of action with multicompound, multitarget, and multipathway[J]. Evid-based Complement Altern Med, 2013, doi: 10.1155/2013/652373.
[21]
Wu L H, Wang Y, Nie J, et al. A network pharmacology approach to evaluating the efficacy of Chinese medicine using genome-wide transcriptional expression data[J]. Evid-based Complement Altern Med, 2013, doi: 10.1155/2013/915343.
[22]
Wu L H, Li X, Yang J H, et al. CHD@ZJU: a knowledgebase providing network-based research platform on coronary heart disease[J]. Database(Oxford), 2013, doi: 10.1093/database/bat047.
[23]
Yang Z Z, Yang J H, Liu W, et al. T2D@ZJU: a knowledgebase integrating heterogeneous connections associated with type 2 diabetes mellitus[J]. Database(Oxford), 2013, doi: 10.1093/database/bat052.
[24]
Li X, Wu L H, Liu W, et al. A network pharmacology study of Chinese medicine Qishen Yiqi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action[J]. PLoS ONE, 2014, 9(5):e95004.
[25]
Wang L L, Li Z, Shao Q, et al. Dissecting active ingredients of Chinese medicine by content-weighted ingredient-target network[J]. Mol Biosyst, 2014, 10(7): 1905.
[26]
Wu L H, Wang Y, Li Z, et al. Identifying roles of "Jun-Chen-Zuo-Shi" component herbs of QishenYiqi formula in treating acute myocardial ischemia by network pharmacology[J]. Chin Med, 2014, 9:24.
[27]
Xiao S, Hao C, Ai N, et al. Deciphering the differentiations of traditional Chinese medicine analogous formulae by parallel liquid chromatography-mass spectrometry coupled with microplate-based assays[J]. Anal Methods, 2014, 6(23): 9283.
[28]
Xiao S, Luo K D, Wen X X, et al. A pre-classification strategy for identification of compounds in traditional Chinese medicine analogous formulas by high-performance liquid chromatography-mass spectrometry[J]. J Pharm Biomed Anal, 2014, 92: 82.
[29]
Zhang Y F, Shi P Y, Yao H, et al. Metabolite profiling and pharmacokinetics of herbal compounds following oral administration of a cardiovascular multi-herb medicine (Qishen Yiqi pills) in rat[J]. Curr Drug Metab, 2012, 13(5): 510.
[30]
Wang S F, Chen L L, Leng J, et al. Fragment ion diagnostic strategies for the comprehensive identification of chemical profile of Gui-Zhi-Tang by integrating high-resolution MS, multiple-stage MS and UV information[J]. J Pharm Biomed Anal, 2014, 98: 22.
[31]
Wang S F, Chen P H, Jiang W, et al. Identification of the effective constituents for anti-inflammatory activity of Ju-Zhi-Jiang-Tang, an ancient traditional Chinese medicine formula[J]. J Chromatogr A, 2014, 1348: 105.
[32]
Wang S F, Chen P H, Xu Y M, et al. Characterization of the chemical constituents in Da-Huang-Gan-Cao-Tang by liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry and liquid chromatography coupled with ion trap mass spectrometry[J]. J Sep Sci, 2014, 37(14): 1748.
[33]
Xiao S, Yu R, Ai N, et al. Rapid screening natural-origin lipase inhibitors from hypolipidemic decoctions by ultrafiltration combined with liquid chromatography-mass spectrometry[J]. J Pharm Biomed Anal, 2015, 104: 67.
[34]
Li Z, Xiao S, Ai N, et al. Derivative multiple reaction monitoring and single herb calibration approach for multiple components quantification of traditional Chinese medicine analogous formulae[J].J Chromatogr A. 2014: doi:10.1016/j.chroma.2014.12.024.
[35]
Cheng Y Y, Wang Y, Wang X W. A causal relationship discovery-based approach to identifying active components of herbal medicine[J]. Comput Biol Chem, 2006, 30(2): 148.
[36]
Wang Y, Yu L Y, Zhang L, et al. A novel methodology for multicomponent drug design and its application in optimizing the combination of active components from Chinese medicinal formula Shenmai[J]. Chem Biol Drug Des, 2010, 75(3): 318.
